广州禾信仪器股份有限公司 2024 年度、2025 年 1-6 月 备考合并财务报表审阅报告 致同会计师事务所（特殊普通合伙） 目 录 审阅报告 | 备考合并资产负债表 | 1-2 | | --- | --- | | 备考合并利润表 | 3 | | 备考合并财务报表附注 | 4-79 | 致同会计师事务所（特殊普通合伙） 中国北京朝阳区建国门外大街 22 号 赛特广场 5 层邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 审阅报告 致同审字（2025）第 440A033743 号 广州禾信仪器股份有限公司全体股东： 我们审阅了后附的广州禾信仪器股份有限公司（以下简称"禾信仪器"） 按照备考合并财务报表附注三所述的编制基础编制的备考合并财务报表，包 括 2024 年 12 月 31 日、2025 年 6 月 30 日的备考合并资产负债表， 2024 年度、 2025 年 1-6 月的备考合并利润表以及备考合并财务报表附注。按照企业会计 准则和备考合并财务报表附注三所述的编制基础编制备考合并财务报表是禾 信仪器管理层的责 ...

上海市锦天城律师事务所 关于广州禾信仪器股份有限公司 发行股份及支付现金购买资产并募集配套资金暨关联交易 之 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11、12 层 电话：021-20511000 传真：021-20511999 邮编：200120 | 声明事项 | 1 | | --- | --- | | 释义 1 | | | 正文 4 | | | 一、 本次交易的方案 | 4 | | 二、 本次交易的交易各方主体资格 | 14 | | 三、 本次交易的批准和授权 | 19 | | 四、 本次交易的相关合同和协议 | 21 | | 五、 本次交易的标的资产情况 | 22 | | 六、 本次交易涉及的债权债务处理及职工安置 | 40 | | 七、 关联交易与同业竞争 | 40 | | 八、 本次交易的信息披露 | 49 | | 九、 相关当事人买卖证券行为的核查 | 50 | | 十、 本次交易具备的实质条件 | 51 | | 十一、 本次交易的证券服务机构 | 60 | | 十二、 结论 | 60 | 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于广州禾信仪器股份有 ...

上海量羲技术有限公司 2023 年度、2024 年度和 2025 年 1-6 月 审计报告 致同会计师事务所（特殊普通合伙） 目 录 | 审计报告 | 1-5 | | --- | --- | | 合并资产负债表 | 1-2 | | 合并利润表 | 3 | | 合并现金流量表 | 4 | | 合并所有者权益变动表 | 5-7 | | 公司资产负债表 | 8-9 | | 公司利润表 | 10 | | 公司现金流量表 | 11 | | 公司所有者权益变动表 | 12-14 | | 财务报表附注 | 15-97 | 致同会计师事务所（特殊普通合伙） 中国北京朝阳区建国门外大街 22 号 赛特广场 5 层邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 审计报告 致同审字（2025）第 440A033616 号 上海量羲技术有限公司全体股东： 一、审计意见 我们审计了上海量羲技术有限公司（以下简称量羲技术）财务报表，包 括 2023 年 12 月 31 日、2024 年 12 月 31 日、2025 年 6 月 30 日的合并及 ...

国泰海通证券股份有限公司 关于 广州禾信仪器股份有限公司发行股份及支付现 金购买资产并募集配套资金暨关联交易 本独立财务顾问报告是依据《公司法》《证券法》《重组管理办法》和《财 务顾问办法》等法律、法规的有关规定，按照证券行业公认的业务标准、道德规 范和诚实信用、勤勉尽责精神，遵循客观、公正的原则，在认真审阅相关资料和 充分了解本次交易行为的基础上，发表独立财务顾问意见，旨在就本次交易做出 独立、客观和公正的评价，以供禾信仪器全体股东及有关方参考。 一、独立财务顾问声明 之 独立财务顾问报告 独立财务顾问 二〇二五年八月 独立财务顾问报告 声明与承诺 国泰海通证券股份有限公司接受禾信仪器的委托，担任本次发行股份及支付 现金购买资产并募集配套资金暨关联交易事宜的独立财务顾问，就该事项向禾信 仪器全体股东提供独立意见，并制作本独立财务顾问报告。 （六）政府有关部门及中国证监会对本独立财务顾问报告内容不负任何责任， 对其内容的真实性、准确性和完整性不作任何保证。任何与之相反的声明均属虚 假不实陈述。同时，本独立财务顾问提醒投资者注意，本报告不构成对禾信仪器 的任何投资建议或意见，对投资者根据本报告做出的任何投资决策 ...

一、审议通过《关于批准本次交易相关审计报告、资产评估报告和备考审 阅报告的议案》 为推进实施本次交易，致同会计师事务所（特殊普通合伙）出具了致同审字 （2025）第440A033616号《上海量義技术有限公司2023年、2024年度及2025年1-6 月审计报告》、北京中同华资产评估有限公司出具的中同华评报字（2025）第 071406号《广州禾信仪器股份有限公司拟发行股份及支付现金购买资产所涉及的 上海量羲技术有限公司股东全部权益价值资产评估报告》、致同会计师事务所（特 殊普通合伙）出具的致同审字（2025）第440A033743号《广州禾信仪器股份有限 公司2024年度、2025年1-6月备考合并财务报表审阅报告》，该等报告将作为相应 申报文件进行报送及信息披露。 广州禾信仪器股份有限公司 第四届董事会独立董事专门会议第一次会议决议 广州禾信仪器股份有限公司(以下简称"公司")第四届董事会独立董事专门 会议第一次会议通知于 2025 年 7 月 18 日以邮件方式发出，并于 2025 年 7 月 25 日以通讯表决形式召开。本次会议由全体独立董事共同推举的陈明先生召集和主 持，会议应出席独立董事 3 人， ...

证券代码：688622 证券简称：禾信仪器 公告编号：2025-042 广州禾信仪器股份有限公司 第四届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广州禾信仪器股份有限公司（以下简称"公司"）第四届董事会第二次会议 于 2025 年 7 月 25 日以邮件方式发出通知，并于 2025 年 8 月 4 日以现场结合通 讯表决形式召开。会议由董事长周振先生主持，会议应到董事 9 名，实到董事 9 名。出席会议人数符合《中华人民共和国公司法》（以下简称"《公司法》"） 和《广州禾信仪器股份有限公司章程》（以下简称"《公司章程》"）等规定， 本次会议的召开及会议形成的决议合法、有效。 二、董事会会议审议情况 出席董事经表决，一致通过如下决议： (一)审议通过《关于 2025 年半年度报告及其摘要的议案》 公司《2025 年半年度报告》及其摘要的编制和审议符合相关法律法规及《公 司章程》的有关规定，报告真实、准确、完整地反映了公司的财务状况和经营情 况，不存在虚假记载、误导性陈述 ...

Group 1 - The stock of HeXin Instruments (688622) closed at 96.02 yuan on July 29, reaching the daily limit with a trading volume of 2.58 billion yuan and a turnover rate of 4.05% [2] - The stock was listed on the daily trading list due to a price increase of 15% at the close [2] - The top five trading departments accounted for a total transaction amount of 1.28 billion yuan, with a net buying amount of 335.27 million yuan [2][3] Group 2 - The main capital inflow for the stock was 9.68 million yuan for the day [3] - The largest buying department was the Shanghai-Hong Kong Stock Connect, with a buying amount of 26.99 million yuan, while the largest selling department was also the Shanghai-Hong Kong Stock Connect, with a selling amount of 11.35 million yuan [3] - Specific buying and selling amounts from various departments were detailed, indicating significant institutional interest [3]

Market Overview - The Shanghai Composite Index closed at 3595.19 points, slightly down by 0.08%, and remains above the six-month moving average [1] - The total trading volume of A-shares reached 1,145.862 billion yuan [1] Stocks Performance - A total of 44 A-shares have surpassed the six-month moving average today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Hexin Instrument (17.10%) - Dekeli (16.12%) - Lais Information (7.54%) [1] - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Junda Co., Ltd. - Taihe Intelligent - Aikodi [1] Notable Stocks - Hexin Instrument (688622) saw a price increase of 20.00% with a turnover rate of 3.28% [1] - Dekeli (688205) increased by 17.49% with a turnover rate of 23.70% [1] - Lais Information (688631) rose by 7.96% with a turnover rate of 7.58% [1] - Other notable stocks include: - Xinganjiang (873167) up by 13.11% - Anpeilong (301413) up by 10.81% [1] Additional Stocks with Positive Movement - Other stocks with positive movement include: - Haiziwang (301078) up by 4.48% - Naxinwei (688052) up by 7.92% - Tianzhun Technology (688003) up by 4.52% [1]

Core Viewpoint - HeXin Instrument has announced the transfer of its 5.3491% equity stake in Anyeep for a total price of 17.6519 million yuan, indicating a strategic move to optimize its asset structure and focus on its core business [2][4]. Summary by Sections Equity Transfer Details - HeXin Instrument will transfer its 5.3491% stake in Anyeep, corresponding to a registered capital of 386,700 yuan, to two entities: Changzhou Huada Songhe Venture Capital Partnership (Limited Partnership) and Suzhou Jingyou Management Consulting Partnership (Limited Partnership) [4]. - The stake will be divided as follows: Huada Songhe will acquire 3.0303% for 10 million yuan, and Jingyou will acquire 2.3188% for 7.6519 million yuan [4]. Financial Implications - The transaction is based on Anyeep's current market valuation and future development prospects, approved by the board and supervisory committee without requiring shareholder approval [4]. - HeXin Instrument expects a positive impact on its comprehensive income post-transaction, subject to audit results [4][5]. Company Background - Anyeep specializes in the research and manufacturing of chemical analysis and medical testing instruments, focusing on mass spectrometry technology [5]. - As of the end of 2024, Anyeep reported total assets of approximately 95.9899 million yuan, with annual revenue of 41.8749 million yuan and a net loss of 4.8234 million yuan [5]. Strategic Intent - The sale aims to optimize HeXin Instrument's asset structure and concentrate on its main business, with no significant impact on its operations or consolidated financial statements [5].

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].